sulpiride has been researched along with 1-methyl-4-phenylpyridinium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rollema, H; Santiago, M; Westerink, BH | 1 |
| Da Prada, M; Keller, HH | 1 |
| Cano, J; Machado, A; Santiago, M | 1 |
| Hikosaka, O; Horikawa, HP; Nakazato, T | 1 |
| Freed, WJ; Kishikawa, M; Takashima, H; Tsujihata, M | 1 |
| Gille, G; Radad, K; Rausch, WD; Reichmann, H | 1 |
6 other study(ies) available for sulpiride and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Responsiveness of striatal dopamine release in awake animals after chronic 1-methyl-4-phenylpyridinium ion-induced lesions of the substantia nigra.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Dopamine; Extracellular Space; Male; Nomifensine; Perfusion; Rats; Rats, Inbred Strains; Stereoisomerism; Substantia Nigra; Sulpiride; Time Factors; Wakefulness | 1991 |
Evidence for the release of 1-methyl-4-phenylpyridinium (MPP+) from rat striatal neurons in vitro.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Antagonists; In Vitro Techniques; Isoquinolines; Male; Neurons; Piperazines; Potassium Chloride; Pyridinium Compounds; Rats; Sulpiride; Temperature; Time Factors | 1985 |
Regulation of prefrontal cortical dopamine release by dopamine receptor agonists and antagonists.
Topics: 1-Methyl-4-phenylpyridinium; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Calcium; Dopamine; Dopamine Agents; Dopamine D2 Receptor Antagonists; Drug Interactions; Male; Microdialysis; Nomifensine; Potassium; Prefrontal Cortex; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Sulpiride; Tetrodotoxin | 1993 |
Duration of catalepsy correlates with increased intrastriatal sulpiride.
Topics: 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electrochemistry; Homovanillic Acid; Male; Microinjections; Neostriatum; Rats; Rats, Sprague-Dawley; Sulpiride; Time Factors | 1997 |
Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Antiparkinson Agents; Antisense Elements (Genetics); Autoreceptors; Bromocriptine; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Fetus; Fluoresceins; Free Radicals; Gene Expression; Levodopa; Mesencephalon; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Sulpiride; Tyrosine 3-Monooxygenase | 1999 |
Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Carbidopa; Cell Count; Cells, Cultured; Dihydroergocryptine; Dopamine; Dopamine Agents; Dopamine Antagonists; Drug Synergism; Female; Lactic Acid; Levodopa; Mice; Neuroglia; Neurons; Pregnancy; Sulpiride; Tyrosine 3-Monooxygenase | 2006 |